Page last updated: 2024-12-07

friedelin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Friedelin is a pentacyclic triterpenoid compound found in various plant species. It has been studied for its potential biological activities, including anti-inflammatory, antioxidant, and anticancer properties. Friedelin has been shown to inhibit the production of pro-inflammatory cytokines and reactive oxygen species, suggesting its potential as a therapeutic agent for inflammatory diseases. Its anticancer effects are attributed to its ability to induce apoptosis and inhibit cell proliferation in various cancer cell lines. The synthesis of friedelin involves complex multi-step reactions, often utilizing natural sources as starting materials. Friedelin's complex structure and diverse biological activities have made it a subject of ongoing research.'

3-friedelanone: from the stem bark of Irvingia gabonensis; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

friedelin : A pentacyclic triterpenoid that is perhydropicene which is substituted by an oxo group at position 3 and by methyl groups at the 4, 4a, 6b, 8a, 11, 11, 12b, and 14a-positions (the 4R,4aS,6aS,6bR,8aR,12aR,12bS,14aS,14bS-enantiomer). It is the major triterpenoid constituent of cork. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID91472
CHEMBL ID485998
CHEBI ID5171
SCHEMBL ID193053
MeSH IDM0168736

Synonyms (41)

Synonym
friedeline
(-)-friedelin
friedelan-3-one
nsc-55141
559-74-0
C08626
friedelin
friedelin, technical grade
bdbm50241943
chebi:5171 ,
CHEMBL485998 ,
3-friedelanone
(4r,4as,6as,6as,6br,8ar,12ar,14as,14bs)-4,4a,6a,6b,8a,11,11,14a-octamethyl-2,4,5,6,6a,7,8,9,10,12,12a,13,14,14b-tetradecahydro-1h-picen-3-one
friedelanone
d:a-friedooleanan-3-one
einecs 209-205-1
d:a-friedooleanan-3-one (van)
nsc 55141
ak21264uad ,
unii-ak21264uad
(4r,4as,6as,6br,8ar,12ar,12bs,14as,14bs)-4,4a,6b,8a,11,11,12b,14a-octamethylicosahydropicen-3(2h)-one
AKOS015897124
CCG-208470
SCHEMBL193053
24,25,26-trinoroleanan-3-one, 5,9,13-trimethyl-, (4.beta.,5.beta.,8.alpha.,9.beta.,10.alpha.,13.alpha.,14.beta.)-
friedelin [mi]
3(2h)-picenone, eicosahydro-4,4a,6b,8a,11,11,12b,14a-octamethyl-, (4r-(4.alpha.,4a.alpha.,6a.beta.,6b.alpha.,8a.alpha.,12a.alpha.,12b.beta.,14a.alpha.,14b.beta.))-
3-oxofriedelane
mfcd00017296
friedelin, analytical standard
sr-05000002227
SR-05000002227-3
SR-05000002227-2
Q15410972
DTXSID101015732
HY-N4110
CS-0032118
fridelin
MS-27536
24,25,26-trinoroleanan-3-one, 5,9,13-trimethyl-,(4b,5b,8a,9b,10a,13a,14b)-
3(2h)-picenone, eicosahydro-4,4a,6b,8a,11,11,12b,14a-octamethyl-, (4r,4as,6as,6br,8ar,12ar,12bs,14as,14bs)-

Research Excerpts

Overview

Friedelin is a triterpenoid derived from green plants. It has a variety of pharmacological functions, such as analgesia, anti-inflammation, antioxidation, and anti-tumor functions.

ExcerptReferenceRelevance
"Friedelin (FR) is a triterpenoid derived from green plants, which has a variety of pharmacological functions, such as analgesia, anti-inflammation, antioxidation, and anti-tumor functions."( Friedelin Alleviates the Pathogenesis of Collagenase-Induced Tendinopathy in Mice by Promoting the Selective Autophagic Degradation of p65.
Jiang, H; Li, Y; Liang, W; Lin, X; Yu, X, 2022
)
2.89

Effects

ExcerptReferenceRelevance
"Friedelin has a unique PT skeleton involving a fascinating nine-step cation shuttle run (CSR) cascade rearrangement reaction, in which the carbocation formed at C2 moves to the other side of the skeleton, runs back to C3 to yield a friedelin cation, which is finally deprotonated."( Structural and Catalytic Insight into the Unique Pentacyclic Triterpene Synthase TwOSC.
Chen, K; Gao, H; Gao, W; Hu, T; Huang, L; Jiang, T; Leng, F; Li, D; Li, Y; Liu, C; Lu, Y; Luo, Y; Ma, X; Qiu, Y; Shen, S; Tong, Y; Tu, L; Wu, R; Zhao, H; Zhou, J, 2023
)
1.63
"Friedelin has a unique PT skeleton involving a fascinating nine-step cation shuttle run (CSR) cascade rearrangement reaction, in which the carbocation formed at C2 moves to the other side of the skeleton, runs back to C3 to yield a friedelin cation, which is finally deprotonated."( Structural and Catalytic Insight into the Unique Pentacyclic Triterpene Synthase TwOSC.
Chen, K; Gao, H; Gao, W; Hu, T; Huang, L; Jiang, T; Leng, F; Li, D; Li, Y; Liu, C; Lu, Y; Luo, Y; Ma, X; Qiu, Y; Shen, S; Tong, Y; Tu, L; Wu, R; Zhao, H; Zhou, J, 2023
)
1.63

Treatment

ExcerptReferenceRelevance
"Treatment with friedelin showed a significant (P<0.05) dose-dependent reduction in pyrexia in rats."( Anti-inflammatory, analgesic and antipyretic effects of friedelin isolated from Azima tetracantha Lam. in mouse and rat models.
Antonisamy, P; Duraipandiyan, V; Ignacimuthu, S, 2011
)
0.96

Pharmacokinetics

ExcerptReferenceRelevance
" In silico analysis of the pharmacokinetic and toxicity properties of the compound was also performed."( Myrianthus libericus: Possible mechanisms of hypoglycaemic action and in silico prediction of pharmacokinetics and toxicity profile of its bioactive metabolite, friedelan-3-one.
Adongo, DW; Amponsah, IK; Baah, MK; Ben, IO; Fleischer, TC; Harley, BK; Mensah, AY; Mireku-Gyimah, NA, 2021
)
0.62

Bioavailability

ExcerptReferenceRelevance
" Friedelan-3-one was shown to be non-carcinogenic, non-hepatotoxic, has decent oral bioavailability and a good compound for optimisation into a drug candidate."( Myrianthus libericus: Possible mechanisms of hypoglycaemic action and in silico prediction of pharmacokinetics and toxicity profile of its bioactive metabolite, friedelan-3-one.
Adongo, DW; Amponsah, IK; Baah, MK; Ben, IO; Fleischer, TC; Harley, BK; Mensah, AY; Mireku-Gyimah, NA, 2021
)
0.62
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (4)

RoleDescription
anti-inflammatory drugA substance that reduces or suppresses inflammation.
non-narcotic analgesicA drug that has principally analgesic, antipyretic and anti-inflammatory actions. Non-narcotic analgesics do not bind to opioid receptors.
antipyreticA drug that prevents or reduces fever by lowering the body temperature from a raised state. An antipyretic will not affect the normal body temperature if one does not have fever. Antipyretics cause the hypothalamus to override an interleukin-induced increase in temperature. The body will then work to lower the temperature and the result is a reduction in fever.
plant metaboliteAny eukaryotic metabolite produced during a metabolic reaction in plants, the kingdom that include flowering plants, conifers and other gymnosperms.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
pentacyclic triterpenoid
cyclic terpene ketoneAn alicyclic ketone in which the carbocyclic ring structure forms part of a terpene skeleton.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (1)

PathwayProteinsCompounds
pentacyclic triterpene biosynthesis210
pentacyclic triterpene biosynthesis1411

Protein Targets (2)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Nitric oxide synthase, inducibleMus musculus (house mouse)IC50 (µMol)50.00000.00103.39119.6000AID344829
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Activation Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
G-protein coupled bile acid receptor 1Homo sapiens (human)EC50 (µMol)10.00000.02372.52598.9000AID444761
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (6)

Processvia Protein(s)Taxonomy
cell surface bile acid receptor signaling pathwayG-protein coupled bile acid receptor 1Homo sapiens (human)
positive regulation of ERK1 and ERK2 cascadeG-protein coupled bile acid receptor 1Homo sapiens (human)
cellular response to bile acidG-protein coupled bile acid receptor 1Homo sapiens (human)
positive regulation of cholangiocyte proliferationG-protein coupled bile acid receptor 1Homo sapiens (human)
regulation of bicellular tight junction assemblyG-protein coupled bile acid receptor 1Homo sapiens (human)
G protein-coupled receptor signaling pathwayG-protein coupled bile acid receptor 1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (3)

Processvia Protein(s)Taxonomy
protein bindingG-protein coupled bile acid receptor 1Homo sapiens (human)
bile acid receptor activityG-protein coupled bile acid receptor 1Homo sapiens (human)
G protein-coupled bile acid receptor activityG-protein coupled bile acid receptor 1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (3)

Processvia Protein(s)Taxonomy
cytoplasmG-protein coupled bile acid receptor 1Homo sapiens (human)
plasma membraneG-protein coupled bile acid receptor 1Homo sapiens (human)
receptor complexG-protein coupled bile acid receptor 1Homo sapiens (human)
plasma membraneG-protein coupled bile acid receptor 1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (40)

Assay IDTitleYearJournalArticle
AID1391720Selectivity index, ratio of CC50 for human HepG2.215 cells to IC50 for Hepatitis B virus infected in human HepG2.215 cells assessed as inhibition of HBeAg secretion2018Bioorganic & medicinal chemistry letters, 05-15, Volume: 28, Issue:9
Design, synthesis and biological evaluation of seco-A-pentacyclic triterpenoids-3,4-lactone as potent non-nucleoside HBV inhibitors.
AID671762Inhibition of HCV NS3 helicase overexpressed in Escherichia coli BL21(DE3) assessed as inhibition of DNA unwinding activity at 10 uM by FRET assay2012Bioorganic & medicinal chemistry letters, Jun-15, Volume: 22, Issue:12
Identification of myricetin and scutellarein as novel chemical inhibitors of the SARS coronavirus helicase, nsP13.
AID1391718Cytotoxicity against human HepG2.215 cells assessed as reduction in cell viability after 3 days by MTT assay2018Bioorganic & medicinal chemistry letters, 05-15, Volume: 28, Issue:9
Design, synthesis and biological evaluation of seco-A-pentacyclic triterpenoids-3,4-lactone as potent non-nucleoside HBV inhibitors.
AID344828Inhibition of NADPH oxidase in LPS-induced mouse BV2 cells assessed as NOX-dependent ROS production at 50 uM2008Bioorganic & medicinal chemistry, Nov-15, Volume: 16, Issue:22
New diterpenoids and the bioactivity of Erythrophleum fordii.
AID466796Growth inhibition of human HL60 cells by MTT assay2010Bioorganic & medicinal chemistry letters, Mar-01, Volume: 20, Issue:5
Triterpene compounds isolated from Acer mandshuricum and their anti-inflammatory activity.
AID671761Inhibition of SARS coronavirus nsP13 helicase activity expressed in Escherichia coli Rosetta assessed inhibition of DNA unwinding activity at 10 uM by FRET assay2012Bioorganic & medicinal chemistry letters, Jun-15, Volume: 22, Issue:12
Identification of myricetin and scutellarein as novel chemical inhibitors of the SARS coronavirus helicase, nsP13.
AID357955Cytotoxicity against human NCI-H460 cells by SRB assay2001Journal of natural products, Oct, Volume: 64, Issue:10
Synthetic secofriedelane and friedelane derivatives as inhibitors of human lymphocyte proliferation and growth of human cancer cell lines in vitro.
AID466799Growth inhibition of human HT-29 cells by MTT assay2010Bioorganic & medicinal chemistry letters, Mar-01, Volume: 20, Issue:5
Triterpene compounds isolated from Acer mandshuricum and their anti-inflammatory activity.
AID444761Agonist activity at TGR5 expressed in CHO cells by CRE-driven luciferase reporter gene assay2010Journal of medicinal chemistry, Jan-14, Volume: 53, Issue:1
Structure-activity relationship study of betulinic acid, a novel and selective TGR5 agonist, and its synthetic derivatives: potential impact in diabetes.
AID383183Inhibition of Saccharomyces sp. alpha-glucosidase2008Journal of natural products, May, Volume: 71, Issue:5
alpha-Glucosidase inhibitory activity of triterpenoids from Cichorium intybus.
AID977602Inhibition of sodium fluorescein uptake in OATP1B3-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM2013Molecular pharmacology, Jun, Volume: 83, Issue:6
Structure-based identification of OATP1B1/3 inhibitors.
AID697852Inhibition of electric eel AChE at 2 mg/ml by Ellman's method2012Bioorganic & medicinal chemistry, Nov-15, Volume: 20, Issue:22
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
AID357956Cytotoxicity against human SF268 cells by SRB assay2001Journal of natural products, Oct, Volume: 64, Issue:10
Synthetic secofriedelane and friedelane derivatives as inhibitors of human lymphocyte proliferation and growth of human cancer cell lines in vitro.
AID697853Inhibition of horse BChE at 2 mg/ml by Ellman's method2012Bioorganic & medicinal chemistry, Nov-15, Volume: 20, Issue:22
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
AID1128496Hepatoprotective activity against H2O2-induced human HepG2 cells assessed as reduction in ALT level at 16.43 uM after 24 hrs (Rvb = 23.22 +/- 1.22 U/L)2014Journal of natural products, Apr-25, Volume: 77, Issue:4
Hepatoprotective effects of triterpenoids from Ganoderma cochlear.
AID1128508Hepatoprotective activity against H2O2-induced human HepG2 cells assessed as reduction in AST level at 16.43 uM after 24 hrs (Rvb = 32.36 +/- 0.79 U/L)2014Journal of natural products, Apr-25, Volume: 77, Issue:4
Hepatoprotective effects of triterpenoids from Ganoderma cochlear.
AID357952Cytotoxicity against human MCF7 cells by SRB assay2001Journal of natural products, Oct, Volume: 64, Issue:10
Synthetic secofriedelane and friedelane derivatives as inhibitors of human lymphocyte proliferation and growth of human cancer cell lines in vitro.
AID444762Agonist activity at TGR5 expressed in CHO cells by CRE-driven luciferase reporter gene assay relative to litocholic acid2010Journal of medicinal chemistry, Jan-14, Volume: 53, Issue:1
Structure-activity relationship study of betulinic acid, a novel and selective TGR5 agonist, and its synthetic derivatives: potential impact in diabetes.
AID466797Growth inhibition of human SKOV3 cells by MTT assay2010Bioorganic & medicinal chemistry letters, Mar-01, Volume: 20, Issue:5
Triterpene compounds isolated from Acer mandshuricum and their anti-inflammatory activity.
AID1128497Hepatoprotective activity against H2O2-induced human HepG2 cells assessed as reduction in ALT level at 32.85 uM after 24 hrs (Rvb = 23.22 +/- 1.22 U/L)2014Journal of natural products, Apr-25, Volume: 77, Issue:4
Hepatoprotective effects of triterpenoids from Ganoderma cochlear.
AID1256912Inhibition of human IDH1 R132H mutant expressed in IPTG-induced Escherichia coli BL21 cells assessed as oxidation of NADPH to NADP+ after 5 mins by spectrophotometry2015Bioorganic & medicinal chemistry letters, Dec-01, Volume: 25, Issue:23
Discovery of α-mangostin as a novel competitive inhibitor against mutant isocitrate dehydrogenase-1.
AID671764Inhibition of HCV NS3 helicase ATP hydrolysis activity overexpressed in Escherichia coli BL21(DE3) assessed as inhibition of inorganic phosphate release by AM/MG-based colometric analysis in the presence of M13 ssDNA2012Bioorganic & medicinal chemistry letters, Jun-15, Volume: 22, Issue:12
Identification of myricetin and scutellarein as novel chemical inhibitors of the SARS coronavirus helicase, nsP13.
AID1391719Selectivity index, ratio of CC50 for human HepG2.215 cells to IC50 for Hepatitis B virus infected in human HepG2.215 cells assessed as inhibition of HBsAg secretion2018Bioorganic & medicinal chemistry letters, 05-15, Volume: 28, Issue:9
Design, synthesis and biological evaluation of seco-A-pentacyclic triterpenoids-3,4-lactone as potent non-nucleoside HBV inhibitors.
AID1128510Hepatoprotective activity against H2O2-induced human HepG2 cells assessed as reduction in AST level at 65.70 uM after 24 hrs (Rvb = 32.36 +/- 0.79 U/L)2014Journal of natural products, Apr-25, Volume: 77, Issue:4
Hepatoprotective effects of triterpenoids from Ganoderma cochlear.
AID1081706Inhibition of photophosphorylation in Spinacia oleracea (spinach) leaves chloroplasts by titrimetry2010Journal of agricultural and food chemistry, Oct-27, Volume: 58, Issue:20
Friedelane triterpenes from Celastrus vulcanicola as photosynthetic inhibitors.
AID1256913Inhibition of human IDH1 expressed in IPTG-induced Escherichia coli BL21 cells assessed as reduction of NADP+ to NADPH after 5 mins by spectrophotometry2015Bioorganic & medicinal chemistry letters, Dec-01, Volume: 25, Issue:23
Discovery of α-mangostin as a novel competitive inhibitor against mutant isocitrate dehydrogenase-1.
AID466798Growth inhibition of human A549 cells by MTT assay2010Bioorganic & medicinal chemistry letters, Mar-01, Volume: 20, Issue:5
Triterpene compounds isolated from Acer mandshuricum and their anti-inflammatory activity.
AID466801Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-stimulated TNFalpha production at 100 nM pretreated 1 hr before LPS challenge measured after 24 hrs by sandwich ELISA relative to control2010Bioorganic & medicinal chemistry letters, Mar-01, Volume: 20, Issue:5
Triterpene compounds isolated from Acer mandshuricum and their anti-inflammatory activity.
AID977599Inhibition of sodium fluorescein uptake in OATP1B1-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM2013Molecular pharmacology, Jun, Volume: 83, Issue:6
Structure-based identification of OATP1B1/3 inhibitors.
AID1128509Hepatoprotective activity against H2O2-induced human HepG2 cells assessed as reduction in AST level at 32.85 uM after 24 hrs (Rvb = 32.36 +/- 0.79 U/L)2014Journal of natural products, Apr-25, Volume: 77, Issue:4
Hepatoprotective effects of triterpenoids from Ganoderma cochlear.
AID1391717Antiviral activity against Hepatitis B virus infected in human HepG2.215 cells assessed as inhibition of HBeAg secretion after 3 days by ELISA2018Bioorganic & medicinal chemistry letters, 05-15, Volume: 28, Issue:9
Design, synthesis and biological evaluation of seco-A-pentacyclic triterpenoids-3,4-lactone as potent non-nucleoside HBV inhibitors.
AID357958Inhibition of PHA-induced human T cell proliferation at 100 uM after 24 hrs by MTT assay2001Journal of natural products, Oct, Volume: 64, Issue:10
Synthetic secofriedelane and friedelane derivatives as inhibitors of human lymphocyte proliferation and growth of human cancer cell lines in vitro.
AID344829Inhibition of iNOS-mediated NO production in LPS-induced mouse BV2 cells2008Bioorganic & medicinal chemistry, Nov-15, Volume: 16, Issue:22
New diterpenoids and the bioactivity of Erythrophleum fordii.
AID444763Agonist activity at human FXR expressed in COS1 cells by luciferase reporter gene assay2010Journal of medicinal chemistry, Jan-14, Volume: 53, Issue:1
Structure-activity relationship study of betulinic acid, a novel and selective TGR5 agonist, and its synthetic derivatives: potential impact in diabetes.
AID357953Cytotoxicity against human TK10 cells by SRB assay2001Journal of natural products, Oct, Volume: 64, Issue:10
Synthetic secofriedelane and friedelane derivatives as inhibitors of human lymphocyte proliferation and growth of human cancer cell lines in vitro.
AID357954Cytotoxicity against human UACC62 cells by SRB assay2001Journal of natural products, Oct, Volume: 64, Issue:10
Synthetic secofriedelane and friedelane derivatives as inhibitors of human lymphocyte proliferation and growth of human cancer cell lines in vitro.
AID1128511Cytotoxicity against human HepG2 cells after 96 hrs by MTT assay2014Journal of natural products, Apr-25, Volume: 77, Issue:4
Hepatoprotective effects of triterpenoids from Ganoderma cochlear.
AID1391716Antiviral activity against Hepatitis B virus infected in human HepG2.215 cells assessed as inhibition of HBsAg secretion after 3 days by ELISA2018Bioorganic & medicinal chemistry letters, 05-15, Volume: 28, Issue:9
Design, synthesis and biological evaluation of seco-A-pentacyclic triterpenoids-3,4-lactone as potent non-nucleoside HBV inhibitors.
AID1128498Hepatoprotective activity against H2O2-induced human HepG2 cells assessed as reduction in ALT level at 65.70 uM after 24 hrs (Rvb = 23.22 +/- 1.22 U/L)2014Journal of natural products, Apr-25, Volume: 77, Issue:4
Hepatoprotective effects of triterpenoids from Ganoderma cochlear.
AID1159550Human Phosphogluconate dehydrogenase (6PGD) Inhibitor Screening2015Nature cell biology, Nov, Volume: 17, Issue:11
6-Phosphogluconate dehydrogenase links oxidative PPP, lipogenesis and tumour growth by inhibiting LKB1-AMPK signalling.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (109)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (0.92)18.7374
1990's10 (9.17)18.2507
2000's40 (36.70)29.6817
2010's45 (41.28)24.3611
2020's13 (11.93)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 35.80

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index35.80 (24.57)
Research Supply Index4.72 (2.92)
Research Growth Index5.73 (4.65)
Search Engine Demand Index46.85 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (35.80)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (0.90%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other110 (99.10%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]